RESEARCH-USE BIOSIMILAR ANTIBODY
Anifrolumab
Monoclonal antibody · IgG1
Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.
TARGETIFNAR1
YMonoclonal antibody
CATALOGSC-BS-777
CATALOG NUMBERSC-BS-777
MOLECULAR WEIGHTApprox. 144.92 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.
Anifrolumab is a recombinant research-use antibody directed against IFNAR1.